CMS Announces First 10 Drugs Subject to Price Negotiation

Halo |

2 years ago

Last updated: 17/10/2023 at 06:47 AM


On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will be subject to negotiation under the Inflation Reduction Act (IRA). The medications were chosen based on criteria outlined in the IRA. The law requires CMS to prioritize drugs with the highest Medicare spending and no competition, among other factors. The resulting list includes medications that millions of Medicare beneficiaries rely on to treat conditions such as cancer, diabetes, blood clots, heart failure, autoimmune conditions, and chronic kidney disease. Price ne

HALO NEWSLETTER

Keep reading HALO with a Free Subscription

unlock this story instantly and join members and pros reading HALO daily -It's Free

See related Articles

Top agents

Gabrielle T

With a background in television and digital platforms, I have honed my skills in relationship management, market researc...

More About Gabrielle T
Wayne Fraser

Being a Life Insurance and Medicare agent is more than just a career for me. It is a calling that stems from a personal ...

More About Wayne Fraser
Eddie Hanson

I have been a broker for 5 years in the medicare industry and I am excited to educate others by providing my knowledge a...

More About Eddie Hanson
Sandra Holmes

Just checking site out

More About Sandra Holmes

Leave a Reply

Today’s update

0

New posts

0

total visitors

0

New subscribers

14

blog read